Listeria monocytogenes: a live vector able to deliver heterologous protein within the cytosol and to drive a CD8 dependent T cell response. NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Listeria monocytogenes: a live vector able to deliver heterologous protein within the cytosol and to drive a CD8 dependent T cell response.

Biologicals. 1995 Jun;23(2):135-43. Unique Identifier : AIDSLINE MED/96012508
Goossens PL; Montixi C; Saron MF; Rodriguez M; Zavala F; Milon G; Unite d'Immunophysiologie cellulaire, Institut Pasteur, Paris,; France.


Abstract: After an introduction on the entry and lifestyle of Listeria monocytogenes within mammalian eucaryotic cells, this chapter gives a brief overview of murine experimental listeriosis. Among the main characteristics of this murine model of infectious/pathogenic processes initiated by a facultative intracellular bacteria, we point out two main recent advances. One relates to Listeria monocytogenes-induced production of cytokines as local, and transient signals able to direct the immune responses along a type 1 pathway of CD4/CD8 T cell differentiation. The other relates (a) to the recognition of L. monocytogenes-reactive CD8+ T lymphocytes as effectors able, once recruited within infected loci, to critically contribute to the complete clearance of the bacteria, and (b) to the recently recognized specificity of some of these CD8 lymphocytes in BALB/c mice. In this paper, we also briefly review (a) the readout assays presently used to monitor the outcome of the infectious/pathogenic processes and the related development and expression of immune responses induced by intravenous inoculation of wild-type virulent or attenuated L. Monocytogenes, (b) why all this information allows us to consider the use of L monocytogenes of attenuated virulence as relevant live recombinant vectors in order to deliver heterologous proteins to the class I processing and presentation pathway, and to induce CD8 T cells along the type 1 pathway.
Keywords: Animal Antigens, CD8/IMMUNOLOGY Bacterial Vaccines/*IMMUNOLOGY Cytokines/BIOSYNTHESIS Cytosol/IMMUNOLOGY CD8-Positive T-Lymphocytes/*IMMUNOLOGY Human Immunity, Cellular Listeria monocytogenes/*IMMUNOLOGY/PHYSIOLOGY Mice Mice, Inbred BALB C Support, Non-U.S. Gov't JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL

KWDanimalantigens,cd8/immunologybacterialvaccines/KWDimmunologycytokines/biosynthesiscytosol/immunologycd8-positivet-lymphocytes/KWDimmunologyhumanimmunity,cellularlisteriamonocytogenes/KWDimmunology/physiologymicemice,inbredbalbcsupport,non-uKWDsKWDgov'tjournalarticlereviewreview,tutorial
960130
M9610763


Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .